This edition presents the progression of large publicly traded health companies’ stock prices from January 1, 2019 through July 1, 2022.  Our key purpose was to summarize stock prices through the COVID pandemic relative to the year before the pandemic began.  While the pandemic has been devastating to thousands of small business, the large publicly traded companies fared pretty well as a group during the pandemic.  Large health companies stock prices fared even better.  Health insurance companies’ stock prices rose faster still, averaging a 55% increase from January 1, 2020 to July 1, 2022).